H<sub>2</sub>S-activatable near-infrared afterglow luminescent probes for sensitive molecular imaging in vivo.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31974383.
- Also identified by DOI 10.1038/s41467-020-14307-y and PMC identifier 6978336.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Afterglow luminescent probes with high signal-to-background ratio show promise for in vivo imaging; however, such probes that can be selectively delivered into target sites and switch on afterglow luminescence remain limited. We optimize an organic electrochromic material and integrate it into near-infrared (NIR) photosensitizer (silicon 2,3-naphthalocyanine bis(trihexylsilyloxide) and (poly[2-methoxy-5-(2-ethylhexyloxy)-1,4-phenylenevinylene]) containing nanoparticles, developing an H<sub>2</sub>S-activatable NIR afterglow probe (F1<sup>2+</sup>-ANP). F1<sup>2+</sup>-ANP displays a fast reaction rate (1563 ± 141 M<sup>-1</sup> s<sup>-1</sup>) and large afterglow turn-on ratio (~122-fold) toward H<sub>2</sub>S, enabling high-sensitivity and -specificity measurement of H<sub>2</sub>S concentration in bloods from healthy persons, hepatic or colorectal cancer patients. We further construct a hepatic-tumor-targeting and H<sub>2</sub>S-activatable afterglow probe (F1<sup>2+</sup>-ANP-Gal) for noninvasive, real-time imaging of tiny subcutaneous HepG2 tumors (<3 mm in diameter) and orthotopic liver tumors in mice. Strikingly, F1<sup>2+</sup>-ANP-Gal accurately delineates tumor margins in excised hepatic cancer specimens, which may facilitate intraoperative guidance of hepatic cancer surgery.
Medical subject headings
- Carcinoma, Hepatocellular
- Hydrogen Sulfide
- Liver Neoplasms
- Luminescent Agents
- Molecular Imaging